US payers support nurse-led TMS therapy

BrainsWay is highlighting increased U.S. payer support for nurse practitioner-administered transcranial magnetic stimulation (TMS) therapy. This growing acceptance is anticipated to broaden access to non-drug treatments for mental health conditions. The development signifies a positive shift in the healthcare landscape, potentially leading to greater adoption of TMS as a viable therapeutic option. This trend could benefit companies involved in TMS technology and treatment delivery by expanding the market and patient reach.